|
|
|
|
|
|
by haldujai
1110 days ago
|
|
|
Not sure if you're specifically referring to the drug in this article but osimertinib has been FDA approved for ~8 years and has been part of routine clinical practice for quite a while now. The system is actually really fast at getting promising cancer therapies into the hands of patients, especially when there aren't good alternatives. Even if something isn't yet approved and the patient is ineligible for a clinical trial, an intervention can be offered to patients under compassionate grounds/special access. |
|
|